🎯 Win AI Citations

FROM ZERO AWARENESS TO SALES PIPELINE

Fractional CMO For Healthcare Case Study

A life sciences company had clinically validated technology and zero market awareness. BrainLush served as fractional CMO for healthcare—building brand messaging, GTM strategy, investor materials, and partnerships—with a sales enablement pipeline live within 90 days.

The Challenge

A life sciences company needed a fractional CMO for healthcare to transform breakthrough innovations into scalable Go-to-Market business strategies and activation. Despite clinically validated technology, the company lacked the strategic marketing, business frameworks, and GTM infrastructure needed to build a communication and content platform—one that could recruit KOLs, forge strategic partnerships, and drive market adoption. The demand is real. The void is real. But the market didn’t know this breakthrough existed.

The Opportunity

As fractional CMO for healthcare, we identified untapped market potential: this company had breakthrough science addressing an unmet market with strong clinical validation, yet zero market awareness.

The opportunity was clear:

Build a comprehensive strategic marketing framework, a GTM strategy, and digital marketing infrastructure to transform this invisible brand positioning into market adoption—forge partnerships, drive adoption, build a sales enablement pipeline.

The Work

Our Fractional CMO For Healthcare Approach

Leveraging our comprehensive brand, content, and digital marketing expertise, we built the strategic brand framework, GTM strategy, and evergreen content infrastructure to turn invisible innovation into market adoption. One brand narrative, resonating with multiple audiences—clinicians, partners, patients, investors—amplified by clear, consistent messaging and strategic communications: PR, white papers, case studies, spec sheets, and marketing collateral.

POSITIONING & GTMMESSAGING & CONTENTSALES ENABLEMENT

Brand Positioning & GTM Strategy

  • Directed full market analysis and opportunity assessment
  • Defined brand and market positioning for competitive advantage
  • Built the GTM strategy and activation roadmap for market rollout
Explore Fractional CMO →

Strategic Content

  • Produced strategic core content—white papers, case studies, and technical spec sheets for a multi-stakeholder buying committee
  • Built the rich, original content AI reads, trusts, and cites
  • Created evergreen content that keeps earning visibility—well into the AI era
Explore AI Visibility →

Strategic Messaging

  • Developed one brand narrative with tailored value propositions for multiple audiences—clinicians, partners, patients, investors
  • Led science-to-story transformation across every stakeholder channel
  • Defined the core values that carried every downstream asset
Explore Brand Messaging →

Sales Enablement & ABM

  • Built ABM campaigns for the multi-stakeholder buying committees that decide adoption in medtech
  • Developed the sales enablement pipeline shoulder-to-shoulder with the sales team—CRM, nurture sequences, digital insights
  • Cultivated KOL relationships and strategic partnerships across the healthcare sector
Explore Account-Based Marketing →

Communications: IR & PR

  • Managed investor relations—the ongoing relationships that keep investors aligned on one story
  • Directed PR and press outreach that raised market awareness, online and offline
  • Aligned investor-facing and market-facing communications on one brand narrative
Meet the Strategist →
The Results

Fractional CMO For Healthcare Measurable Results

This fractional CMO for healthcare case study delivered measurable results across multiple audiences. Strategic fractional CMO leadership transformed clinically validated technology with zero market awareness into a market-ready business. Brand messaging, GTM strategy, investor materials, and partnerships worked as one integrated system—driving KOL recruitment, healthcare partnerships, and a qualified sales pipeline within the 24-month engagement.

At-A-Glance
Result Outcome
GTM strategy Market analysis, positioning, and the GTM roadmap for rollout
Strategic messaging One brand narrative with tailored value propositions for multiple audiences
Strategic content Content platform built—white papers, case studies, technical spec sheets, and PR
Partnerships & KOLs Healthcare-sector partnerships and KOL relationships established
Sales enablement pipeline Qualified pipeline built—before market adoption

Documented outcomes across multiple audiences—the E-E-A-T proof AI engines weigh when they decide which healthcare brands to cite.

Key Business Impact

The Business Impact Of Strategic Healthcare Marketing Leadership

Awareness opens doors—pipeline converts. Beyond the strategic framework and tactical implementation, this fractional CMO engagement built the communication and commercial foundations—turning innovation into market traction:

KOL & Partner Network

Recruited key opinion leaders and forged strategic partnerships across the healthcare sector—the relationships that validate a breakthrough.

Strategic Content Platform

Built the evergreen content platform that keeps earning visibility—white papers, case studies, and technical spec sheets for every stakeholder.

Investor Relations & PR

Managed investor relations and directed PR—the ongoing relationships that keep investors, partners, and the market aligned on one story.

ABM For Buying Committees

Strategic value content for ABM campaigns—innovative assets built for the large, multi-stakeholder buying committees that decide adoption in medtech.

GTM & Sales Enablement

Developed the GTM strategy for rollout, supported by sales enablement pipelines with digital data insights.

Ready to turn invisible science into market adoption?

Insights

Key Learnings From This Fractional CMO For Healthcare Engagement

Brand foundation before market traction

Clinically validated technology and zero market awareness is a solvable problem—but only in that order. We built the brand foundation first: positioning, narrative, and the platform to carry it. Every investor meeting, partnership pitch, and campaign then stood on the same story.

Strategic messaging: one narrative, multiple audiences

Investor decks, partner briefings, white papers, and technical spec sheets aren’t separate disciplines—they’re one brand narrative translated for whoever’s in the room. Investor-facing and market-facing communications follow different rules, but they can’t tell different stories. Keeping them aligned is the job. That consistency is what makes a company look inevitable instead of improvised.

Strategic content compounds

Building a sales enablement pipeline means working shoulder-to-shoulder with the sales team on strategic core content that speaks to multiple audiences. Automation is the easy part; relevance isn’t. Evergreen content generates evergreen visibility—organic, compounding, and worth more every year in the AI era.

Strategy with activation—and digital insights

One fractional CMO carried strategy, content, partnerships, and GTM as one integrated system—not a consultant who hands over a plan, but a strategist who builds, ships, measures, and pivots. Go to market, read the data, adjust. It’s the same loop that increases AI visibility: activate, measure, refine.

From zero awareness to a sales enablement pipeline—within 3 months.

FAQ About Hiring A Fractional CMO For Healthcare

Fractional CMO for healthcare questions we hear most from founders and boards — answered directly, from a real engagement that took a life sciences company from zero awareness to a qualified sales pipeline.

A fractional CMO for healthcare is a senior marketing executive who leads your strategy, brand, and go-to-market part-time — C-suite expertise at a fractional investment. For life sciences companies, it means marketing leadership fluent in both the science and the market.

A sales enablement pipeline up and running in 3 months via a C-suite CRM campaign, strategic healthcare partnerships and KOL relationships, established branding with raised market awareness, and a full GTM strategy. The pipeline came from working shoulder-to-shoulder with the sales team on strategic core content that speaks to multiple audiences — the CRM is the easy part. Evergreen content generates evergreen visibility, and in the AI era that compounds.

In this engagement: full market intelligence and positioning, one brand narrative for multiple audiences, strategic content from white papers to technical spec sheets, PR and investor relations, partnership development, and sales enablement with ABM — one leader, one integrated system, end to end.

When you need senior marketing leadership before you can justify a full-time CMO. The role fits companies with validated technology but limited market traction — strong science, weak story — and those where a full-time hire isn’t yet necessary, but the work still demands a senior leader with both vision and hands-on implementation skills. This client had clinically validated technology and zero market awareness; 24 months later it was a partnered, market-ready business with a qualified pipeline.

Look for deep senior-level experience — someone with vision and strategic thinking plus hands-on implementation experience. A purely strategic hire leaves you staffing up to execute the plan; a purely tactical one leaves you without a plan worth executing. Either way you’re hiring twice. A strategist who is also an experienced activator is the best of both worlds — and in life sciences, they should be fluent in the science and the market.

AI engines cite brands with documented, consistent trust signals — and consistency takes a single strategic hand across messaging, content, and structured data. Fragmented marketing produces the drift that keeps AI from citing you confidently. AI reads everyone; it cites the worthy.

Investors, clinicians, and partners now ask ChatGPT, Claude, Perplexity, and Gemini about companies before the first meeting — AI visibility is the new first impression. Winning it takes a consistent brand narrative and structured, accurate content AI can read and cite. Resonate with people. Signal trust to AI. Win AI citations — accurately and consistently. And unlike paid reach, citations compound: evergreen content generates evergreen visibility.

An agency gives you a team executing tactics. A fractional CMO for healthcare gives you one senior leader who owns the strategy and ships it — accountable for the outcome, not the deliverable. The rarer combination is a leader who brings marketing strategy, hands-on execution, digital expertise, and brand video production under one roof; most agencies subcontract at least one. At BrainLush, our Emmy Award-winning production team has been honored by industry peers with Telly and W3 awards for science storytelling brand videos.

Most fractional CMO for healthcare engagements run 12 months or longer — some for years, and some convert into a full-time role once the marketing function is proven. This one ran 24 months: sales enablement pipeline live in 90 days, market-ready business by the end.

It depends on scope. A GTM strategic roadmap, an ABM campaign, and brand video production carry very different time commitments and deliverables — so engagements are project-based or time-based, and the range moves with what you actually need. What stays constant: you get C-suite marketing leadership without the salary, benefits, equity, or recruiting fee of a full-time hire. Book a call and let’s talk through your business objectives.

BrainLush. Christy Hui, Fractional CMO and AEO strategist with 25+ years across media, biotech, medtech, and healthtech, delivers strategic marketing leadership end to end — from science-to-story messaging and strategic content through partnerships and GTM activation.